Disrupting TNF signaling in pancreatic cancer: A phase I/II clinical study in patients with advanced disease.

被引：0
|
作者：
Kosuri, KV [1 ]
Bekaii-Saab, T [1 ]
Bender, J [1 ]
Criswell, T [1 ]
Kane, Y [1 ]
Chidiac, T [1 ]
Young, D [1 ]
Guttridge, D [1 ]
Caligiuri, M [1 ]
Villalona-Calero, M [1 ]
机构：
[1] Ohio State Univ, James Carter Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：333S / 333S
页数：1
相关论文
共 50 条
  • [31] Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer
    Sharma, JJ
    Razvillas, B
    Stephens, CD
    Hilsenbeck, SG
    Sharma, A
    Rothenberg, ML
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (04) : 361 - 364
  • [32] A phase II study of gastrimmune in advanced pancreatic cancer.
    Brett, BT
    Smith, SC
    Bouvier, CV
    Michaeli, D
    Hochhauser, D
    Davidson, BR
    Kurzawinski, TR
    Watkinson, T
    Van-Someren, N
    Pounder, RE
    Caplin, ME
    GASTROENTEROLOGY, 2000, 118 (04) : A642 - A642
  • [33] A phase II study of gemcitabine and flutamide in advanced pancreatic cancer
    Mayer, A
    Shaw, J
    'Ath, SD
    Price, P
    Blesing, C
    Corrie, P
    BRITISH JOURNAL OF CANCER, 2000, 83 : 18 - 18
  • [34] A phase II study of Temozolomide in advanced untreated pancreatic cancer
    Moore, MJ
    Feld, R
    Hedley, D
    Oza, A
    Siu, LL
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 77 - 79
  • [35] A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer
    Tomao, S
    Romiti, A
    Massidda, B
    Ionta, MI
    Farris, A
    Zullo, A
    Brescia, A
    Santuari, L
    Frati, L
    ANTICANCER RESEARCH, 2002, 22 (04) : 2361 - 2364
  • [36] A phase II study of Temozolomide in advanced untreated pancreatic cancer
    Malcolm J. Moore
    Ron Feld
    David Hedley
    Amit Oza
    Lillian L. Siu
    Investigational New Drugs, 1998, 16 : 77 - 79
  • [37] Phase I/II Study of FOLFIRI in Japanese Patients with Advanced Colorectal Cancer
    Yamashita, Keishi
    Nagashima, Fumio
    Fujita, Ken-ichi
    Yamamoto, Wataru
    Endo, Hisashi
    Miya, Toshimichi
    Narabayashi, Masaru
    Kawara, Kaori
    Akiyama, Yuko
    Ando, Yuichi
    Ando, Masahiko
    Sasaki, Yasutsuna
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (02) : 204 - 209
  • [38] Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer
    Saif, Muhammad W.
    Podoltsev, Nikolai A.
    Rubin, Mark S.
    Figueroa, Jose A.
    Lee, Minyoung Y.
    Kwon, Jinwon
    Rowen, Elin
    Yu, Jaewon
    Kerr, Robert O.
    CANCER INVESTIGATION, 2010, 28 (02) : 186 - 194
  • [39] Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study
    Suzuki, Nobuaki
    Hazama, Shoichi
    Iguchi, Haruo
    Uesugi, Kazuhiro
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Aruga, Atsushi
    Hatori, Takashi
    Ishizaki, Hidenobu
    Umeda, Yuzo
    Fujiwara, Toshiyoshi
    Ikemoto, Tetsuya
    Shimada, Mitsuo
    Yoshimatsu, Kazuhiko
    Shimizu, Ryoichi
    Hayashi, Hiroto
    Sakata, Koichiro
    Takenouchi, Hiroko
    Matsui, Hiroto
    Shindo, Yoshitaro
    Iida, Michihisa
    Koki, Yasunobu
    Arima, Hideki
    Furukawa, Hiroyuki
    Ueno, Tomio
    Yoshino, Shigefumi
    Nakamura, Yusuke
    Oka, Masaaki
    Nagano, Hiroaki
    CANCER SCIENCE, 2017, 108 (01) : 73 - 80
  • [40] Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study
    Yamaue, Hiroki
    Tsunoda, Takuya
    Tani, Masaji
    Miyazawa, Motoki
    Yamao, Kenji
    Mizuno, Nobumasa
    Okusaka, Takuji
    Ueno, Hideki
    Boku, Narikazu
    Fukutomi, Akira
    Ishii, Hiroshi
    Ohkawa, Shinichi
    Furukawa, Masayuki
    Maguchi, Hiroyuki
    Ikeda, Masafumi
    Togashi, Yosuke
    Nishio, Kazuto
    Ohashi, Yasuo
    CANCER SCIENCE, 2015, 106 (07) : 883 - 890
12345